CHRM3 and colorectal carcinoma: Our model differs from the reported data in that we (1) treated an orthotopic human tumor xenograft as opposed to preventing tumorigenesis, and (2) used a drug instead of CHRM3 ablation, simulating a scenario that is more similar to the situation of CRC patients.